In Jan. 2005, the U.S. Food and Drug Administration (FDA) approved an albumin-stabilized nanoparticle formulation of paclitaxel (Abraxane)…
In 2005, The Patient Navigator Research Program (PNRP), a National Cancer Institute initiative, was underway to assess the…
In 2005, The Center for Drug Discovery was established at the University of Georgia to fulfill a critical…
In 2005, the Penn Cardiovascular Institute (CVI) was established as a collaborative multi-disciplinary group of basic and translational…
On Dec. 26, 2004, the U.S. Centers for Disease Control and Prevention (CDC) assisted with an earthquake measuring…
On Dec. 10, 2004, a National Cancer Institute (NCI) supported study determined that a new molecular test done…
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 14, 2004, Pacific Northwest National Laboratory (PNNL) announced it had received a $10.3 million biodefense contract…
On Aug. 19, 2004, the HudsonAlpha Institute for Biotechnology was formally created in Huntsville, Alabama, by Jim Hudson…
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
On Jun. 3, 2004, the National Cancer Institute’s (NCI) Annual Report to the Nation found cancer incidence and…
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
On May 6, 2004, the Health Sciences Learning Center opened near the University of Wisconsin Hospital and Clinics. The…
On Apr. 24, 2004, the Virginia Bioinformatics Institute (VBI), opened its new 59,000-square-foot Bioinformatics Facility I, Virginia Bioinformatics…
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
In 2004, The Division of Global Migration and Quarantine, part of the CDC’s National Center for Infectious Diseases,…
In 2004, the U.S. Congress passed the Anabolic Steroid Control Act which enacted a ban on over-the-counter steroid…
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…
On Jan. 20, 2005, the Siteman Cancer Center received National Cancer Institute (NCI) designation as a Comprehensive Cancer…